AD

Alan Dunton

Recce Pharmaceuticals Ltd | Non-Executive Director
Dr Dunton brings experience with over three decades in senior pharmaceutical roles. Notably, he served as the President and Managing Director of the Janssen Research Foundation (J&J Research). He is a member of Risk Committee.

Company and Role

Company
Title
Tenure
Since
RCE
RCE
Recce Pharmaceuticals Ltd
  • Non-Executive Director
4yrs, 8mthJul 2020

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RCE
RCE
Recce Pharmaceuticals Ltd
14/11/24116,81910,0003,375,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RCE
RCE
Recce Pharmaceuticals Ltd
14/11/24
Issued
2,250,000$0.244$549,000Issue of options
RCE
RCE
Recce Pharmaceuticals Ltd
07/12/23
Issued
56,819$0.440$25,000Rights issue
RCE
RCE
Recce Pharmaceuticals Ltd
22/02/21
Issued
1,125,000$1.030$1,158,750Issue of options
RCE
RCE
Recce Pharmaceuticals Ltd
04/12/20
Issued
60,000$1.220$73,200Director remuneration